Management of Pulmonary Arterial Hypertension Associated with Congenital Systemic-to-Pulmonary Shunts and Eisenmenger's Syndrome

Author： Galie Nazzareno

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.68, Iss.8, 2008-01, pp. : 1049-1066

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tadalafil: In Pulmonary Arterial Hypertension

By Croxtall Jamie D. Lyseng-Williamson Katherine A.

Drugs, Vol. 70, Iss. 4, 2010-03 ,pp. : 479-488

Adis International

Access to resources Recommend Favorite

Terguride for pulmonary arterial hypertension

By Antoniu Sabina A

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 11, 2011-11 ,pp. : 1333-1335

Informa Healthcare

Access to resources Recommend Favorite

Sitaxentan: In Pulmonary Arterial Hypertension

By Scott Lesley J.

Drugs, Vol. 67, Iss. 5, 2007-01 ,pp. : 761-770

Adis International

Access to resources Recommend Favorite

Bosentan: A Review of its Use in Pulmonary Arterial Hypertension and Systemic Sclerosis

By Oldfield Vicki Lyseng-Williamson Katherine A.

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 3, 2006-01 ,pp. : 189-208

Adis International

Access to resources Recommend Favorite

Bosentan: A Review of its Use in the Management of Mildly Symptomatic Pulmonary Arterial Hypertension

By Dhillon Sohita Keating Gillian M.

American Journal of Cardiovascular Drugs, Vol. 9, Iss. 5, 2009-10 ,pp. : 331-350

Adis International

Access to resources Recommend Favorite